OSRH
HEALTHCAREBellevue Life Sciences Acquisition Corp
Live · NASDAQ · May 9, Close
What's Moving OSRH Today?
No stock-specific AI insight has been generated for OSRH yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.58
Fundamentals
Trading
OSRH News
20 articles- Presenting on Emerging Growth Conference 92 Day 2 on May 7; Register to live streamYahoo Finance·May 6, 2026
- Emerging Growth Research Issues Flash Report on OSR Holdings, Reaffirms Buy-Emerging Rating and $10.00 Price TargetYahoo Finance·May 5, 2026
- OSR Holdings to Present VXM01 Licensing Agreement at Emerging Growth Conference May 7, 2026Yahoo Finance·Apr 30, 2026
- OSR Holdings Executes Definitive $815 Million Global License Agreement for VXM01 with BCM EuropeYahoo Finance·Apr 29, 2026
- OSR Holdings Eliminates $2.02 Million Warrant Overhang with Premium-Priced Convertible NoteYahoo Finance·Apr 9, 2026
- Presenting on Emerging Growth Conference 91 Day 1 on April 1; Register to live streamYahoo Finance·Mar 31, 2026
- OSR Holdings to Update Investors at the Emerging Growth Conference on April 1, 2026Yahoo Finance·Mar 30, 2026
- Emerging Growth Research Issues Flash Report on OSR Holdings, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price TargetYahoo Finance·Mar 27, 2026
- OSR Holdings Updates $815 Million VXM01 Licensing Deal Structure to Capture Value at Parent LevelYahoo Finance·Mar 23, 2026
- Woori IO, an OSR Company, Signs NDA with Sinopharm for China Market and Global Multicenter TrialsYahoo Finance·Mar 19, 2026
- Woori IO, an OSR Company, Signs NDA with Sinopharm to Explore China Commercial OpportunitiesYahoo Finance·Mar 19, 2026
- OSR Holdings, Inc. Granted 180-Day Nasdaq Extension; Reaffirms Strategic MomentumYahoo Finance·Mar 5, 2026
- CEO Statement to ShareholdersYahoo Finance·Feb 2, 2026
- OSR Holdings Completes Woori IO Acquisition, Secures Long-Term Shareholder Alignment, and Reviews Strategic Combination of Medical Device SubsidiariesYahoo Finance·Jan 27, 2026
- Woori IO, an OSR Company, Highlights FDA Clarification on Non-Medical Wearables as a Catalyst for Accelerated Commercial LaunchYahoo Finance·Jan 22, 2026
- Vaximm Appoints Sébastien Wieckowski, PhD, as Chief Scientific Officer to Advance Next-Generation Oral Immunotherapy PlatformYahoo Finance·Jan 16, 2026
- Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR HoldingsYahoo Finance·Dec 19, 2025
- Presenting on Emerging Growth Conference 88 Day 2 on December 11; Register to live streamYahoo Finance·Dec 10, 2025
- Presenting on Emerging Growth Conference 88 Day 1 on December 10; Register to live streamYahoo Finance·Dec 9, 2025
- Emerging Growth Research Issues Flash Report on OSR Holdings, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target Following Major Licensing AgreementYahoo Finance·Dec 4, 2025
All 20 articles loaded
Price Data
52-Week Range
$0.58
Fundamentals
Trading
About Bellevue Life Sciences Acquisition Corp
OSR Holdings Inc. is a leading provider of integrated managed services specializing in asset management and financial advisory solutions for institutional clients. By harnessing advanced technology and fostering strategic partnerships, the company not only enhances operational efficiency but also broadens its extensive service offerings. OSR Holdings places a strong emphasis on sustainable growth and client-centric value maximization, setting itself apart in a competitive landscape through its dedication to innovation and exceptional customer service. With a keen focus on emerging market opportunities, the firm maintains a rigorous risk management framework to ensure long-term stability and success.